Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Association between Urinary Diversion Type and Other-Cause Mortality in Radical Cystectomy Patients.
Morra S, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, Goyal JA, Touma N, Tian Z, Saad F, Califano G, Creta M, Celentano G, Shariat SF, Ahyai S, Carmignani L, de Cobelli O, Musi G, Briganti A, Chun FKH, Longo N, Karakiewicz PI. Morra S, et al. Among authors: de angelis m, de cobelli o. Cancers (Basel). 2024 Jan 19;16(2):429. doi: 10.3390/cancers16020429. Cancers (Basel). 2024. PMID: 38275870 Free PMC article.
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
Stabile A, Pellegrino A, Mazzone E, Cannoletta D, de Angelis M, Barletta F, Scuderi S, Cucchiara V, Gandaglia G, Raggi D, Necchi A, Karakiewicz P, Montorsi F, Briganti A. Stabile A, et al. Among authors: de angelis m. Eur Urol Oncol. 2022 Feb;5(1):1-17. doi: 10.1016/j.euo.2021.08.001. Epub 2021 Sep 17. Eur Urol Oncol. 2022. PMID: 34538770 Review.
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis.
Del Giudice F, Flammia RS, Chung BI, Moschini M, Pradere B, Mari A, Soria F, Albisinni S, Krajewski W, Szydełko T, Laukhtina E, D'Andrea D, Gallioli A, Mertens LS, Maggi M, Sciarra A, Salciccia S, Ferro M, Scornajenghi CM, Asero V, Cattarino S, De Angelis M, Cacciamani GE, Autorino R, Pandolfo SD, Falagario UG, D'Altilia N, Mancini V, Chirico M, Cinelli F, Bettocchi C, Cormio L, Carrieri G, De Berardinis E, Busetto GM, On Behalf Of European Association Of Urology Eau-Young Academic Urologists Yau Urothelial Cancer Working Party. Del Giudice F, et al. Among authors: de berardinis e, de angelis m. Cancers (Basel). 2022 Feb 10;14(4):887. doi: 10.3390/cancers14040887. Cancers (Basel). 2022. PMID: 35205635 Free PMC article.
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series.
Pellegrino F, Stabile A, Mazzone E, Sorce G, Barletta F, De Angelis M, Brembilla G, Gandaglia G, De Cobelli F, Montorsi F, Briganti A. Pellegrino F, et al. Among authors: de angelis m, de cobelli f. Prostate. 2022 Sep;82(12):1170-1175. doi: 10.1002/pros.24368. Epub 2022 May 10. Prostate. 2022. PMID: 35538401
Understanding the Role of Ureteral Access Sheath in Preventing Post-Operative Infectious Complications in Stone Patients Treated with Ureteroscopy and Ho:YAG Laser Lithotripsy: Results from a Tertiary Care Referral Center.
Villa L, Dioni P, Candela L, Ventimiglia E, De Angelis M, Corsini C, Robesti D, Fantin M, D'Arma A, Proietti S, Giusti G, Kartalas Goumas I, Briganti A, Montorsi F, Salonia A. Villa L, et al. Among authors: de angelis m. J Clin Med. 2023 Feb 12;12(4):1457. doi: 10.3390/jcm12041457. J Clin Med. 2023. PMID: 36835992 Free PMC article.
Oncological and perioperative outcomes of surgery with or without metastasis-directed therapy as part of a multimodal treatment in men with de-novo oligometastatic prostate cancer.
Pellegrino A, Gandaglia G, de Angelis M, Fallara G, Mazzone E, Stabile A, Pellegrino F, Robesti D, Leni R, Scuderi S, Cucchiara V, Cirulli GO, Barletta F, Montorsi F, Briganti A. Pellegrino A, et al. Among authors: de angelis m. World J Urol. 2023 Aug;41(8):2069-2076. doi: 10.1007/s00345-023-04460-6. Epub 2023 Jun 16. World J Urol. 2023. PMID: 37326656
Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis.
Morra S, Incesu RB, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, Goyal JA, Tian Z, Saad F, Califano G, la Rocca R, Capece M, Shariat SF, Ahyai S, Carmignani L, de Cobelli O, Musi G, Tilki D, Briganti A, Chun FKH, Longo N, Karakiewicz PI. Morra S, et al. Among authors: de angelis m, de cobelli o. Cancers (Basel). 2023 Sep 10;15(18):4498. doi: 10.3390/cancers15184498. Cancers (Basel). 2023. PMID: 37760467 Free PMC article.
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score.
Pellegrino F, Stabile A, Sorce G, Quarta L, Robesti D, Cannoletta D, Cirulli G, Barletta F, Scuderi S, Mazzone E, de Angelis M, Brembilla G, De Cobelli F, Salonia A, Montorsi F, Briganti A, Gandaglia G. Pellegrino F, et al. Among authors: de angelis m, de cobelli f. Eur Urol Focus. 2024 Jul;10(4):634-640. doi: 10.1016/j.euf.2023.10.006. Epub 2023 Oct 19. Eur Urol Focus. 2024. PMID: 37865591
1,418 results